In this episode, we break down the intricacies of Nvidia's substantial $50 million investment in Recursion, emphasizing the growing synergy between AI and drug discovery. Join me for a closer look at the financial maneuvers shaping the future of medical advancements.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
